Publications Julia Hess
Front. Immunol. 14:1270493 (2023)
Budeus, B. ; Unger, K. ; Hess J. ; Sentek, H. ; Klein, D.
Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts.
Cancers 15:16 (2023)
Burkart, S. ; Weusthof, C. ; Khorani, K. ; Steen, S. ; Stögbauer, F. ; Unger, K. ; Hess J. ; Zitzelsberger, H. ; Belka, C. ; Kurth, I. ; Hess, J.
A novel subgroup of UCHL1-related cancers is associated with genomic instability and sensitivity to DNA-damaging treatment.
Radiat. Oncol. 18:51 (2023)
Schnöller, L.E. ; Piehlmaier, D. ; Weber, P. ; Brix, N. ; Fleischmann, D.F. ; Nieto, A.E. ; Selmansberger, M. ; Heider, T. ; Hess J. ; Niyazi, M. ; Belka, C. ; Lauber, K. ; Unger, K. ; Orth, M.
Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data.
Clin. Transl. Radiat. Oncol. 39:100586 (2023)
Unger, K. ; Hess J. ; Link, V. ; Buchner, A. ; Eze, C. ; Li, M. ; Stief, C. ; Kirchner, T. ; Klauschen, F. ; Zitzelsberger, H. ; Niyazi, M. ; Ganswindt, U. ; Schmidt-Hegemann, N.S. ; Belka, C.
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score.